Deo SV, Sundaram V, Wilson B, et al. - Since there exist limited data concerning 10-year survival as well as adverse cardiovascular events in patients with metabolic syndrome (MET) following coronary artery bypass grafting (CABG), researchers performed a comparison of 10-year events rates for veterans receiving isolated CABG stratified by presence of metabolic syndrome (MET+) vs without (MET–). A rise in the prevalence of MET was observed from 27.88% in 2005 to 34.02% in 2014. Participants in the MET+ group were likely younger, White, and had more peripheral vascular disease. A median follow-up of 6.5 years was performed, which revealed similar survival; however, higher risks for myocardial infarction and recurrent admissions for congestive heart failure were observed in relation to MET. Overall, findings showed higher 10-year cardiovascular event rates in patients with metabolic syndrome receiving CABG.